United States · FDA National Drug Code directory

OLANZAPINE

Source ingredient · 238 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 0093-5505_debcba63-033a-446f-a086-ccdf9d790662

Olanzapine and Fluoxetine

CAPSULE / Teva Pharmaceuticals USA, Inc.

United States · Source reference 0093-5506_debcba63-033a-446f-a086-ccdf9d790662

Olanzapine and Fluoxetine

CAPSULE / Teva Pharmaceuticals USA, Inc.

United States · Source reference 0093-5507_debcba63-033a-446f-a086-ccdf9d790662

Olanzapine and Fluoxetine

CAPSULE / Teva Pharmaceuticals USA, Inc.

United States · Source reference 42291-652_4135db41-e022-f3a8-e063-6394a90a3681

Olanzapine and Fluoxetine

CAPSULE / AvKARE

United States · Source reference 42291-653_4135db41-e022-f3a8-e063-6394a90a3681

Olanzapine and Fluoxetine

CAPSULE / AvKARE

United States · Source reference 42291-654_4135db41-e022-f3a8-e063-6394a90a3681

Olanzapine and Fluoxetine

CAPSULE / AvKARE

United States · Source reference 42291-655_4135db41-e022-f3a8-e063-6394a90a3681

Olanzapine and Fluoxetine

CAPSULE / AvKARE

United States · Source reference 42291-656_4135db41-e022-f3a8-e063-6394a90a3681

Olanzapine and Fluoxetine

CAPSULE / AvKARE

United States · Source reference 49884-250_b06f7f64-c457-4ca9-ad33-61efa6aec9b0

Olanzapine and Fluoxetine

CAPSULE / Par Health USA, LLC

United States · Source reference 49884-251_b06f7f64-c457-4ca9-ad33-61efa6aec9b0

Olanzapine and Fluoxetine

CAPSULE / Par Health USA, LLC

United States · Source reference 49884-252_b06f7f64-c457-4ca9-ad33-61efa6aec9b0

Olanzapine and Fluoxetine

CAPSULE / Par Health USA, LLC

United States · Source reference 49884-253_b06f7f64-c457-4ca9-ad33-61efa6aec9b0

Olanzapine and Fluoxetine

CAPSULE / Par Health USA, LLC

United States · Source reference 49884-277_b06f7f64-c457-4ca9-ad33-61efa6aec9b0

Olanzapine and Fluoxetine

CAPSULE / Par Health USA, LLC

United States · Source reference 61269-640_40d4ed67-c51d-40d0-8a32-ecfdbf069f9a

ZYPREXA Intramuscular

INJECTION, POWDER, FOR SOLUTION / H2-Pharma LLC

United States · Source reference 61269-650_40d4ed67-c51d-40d0-8a32-ecfdbf069f9a

ZYPREXA Zydis

TABLET, ORALLY DISINTEGRATING / H2-Pharma LLC

United States · Source reference 61269-651_40d4ed67-c51d-40d0-8a32-ecfdbf069f9a

ZYPREXA Zydis

TABLET, ORALLY DISINTEGRATING / H2-Pharma LLC

United States · Source reference 61269-652_40d4ed67-c51d-40d0-8a32-ecfdbf069f9a

ZYPREXA Zydis

TABLET, ORALLY DISINTEGRATING / H2-Pharma LLC

United States · Source reference 61269-653_40d4ed67-c51d-40d0-8a32-ecfdbf069f9a

ZYPREXA Zydis

TABLET, ORALLY DISINTEGRATING / H2-Pharma LLC

United States · Source reference 61269-630_40d4ed67-c51d-40d0-8a32-ecfdbf069f9a

Zyprexa

TABLET / H2-Pharma LLC

United States · Source reference 61269-631_40d4ed67-c51d-40d0-8a32-ecfdbf069f9a

Zyprexa

TABLET / H2-Pharma LLC

United States · Source reference 61269-632_40d4ed67-c51d-40d0-8a32-ecfdbf069f9a

Zyprexa

TABLET / H2-Pharma LLC

United States · Source reference 61269-633_40d4ed67-c51d-40d0-8a32-ecfdbf069f9a

Zyprexa

TABLET / H2-Pharma LLC

United States · Source reference 61269-634_40d4ed67-c51d-40d0-8a32-ecfdbf069f9a

Zyprexa

TABLET / H2-Pharma LLC

United States · Source reference 61269-635_40d4ed67-c51d-40d0-8a32-ecfdbf069f9a

Zyprexa

TABLET / H2-Pharma LLC

United States · Source reference 69452-561_f836e1a2-2082-49cf-bf45-34e36c120c58

olanzapine

TABLET, ORALLY DISINTEGRATING / Bionpharma Inc.

United States · Source reference 69452-562_f836e1a2-2082-49cf-bf45-34e36c120c58

olanzapine

TABLET, ORALLY DISINTEGRATING / Bionpharma Inc.

United States · Source reference 69452-563_f836e1a2-2082-49cf-bf45-34e36c120c58

olanzapine

TABLET, ORALLY DISINTEGRATING / Bionpharma Inc.

United States · Source reference 69452-564_f836e1a2-2082-49cf-bf45-34e36c120c58

olanzapine

TABLET, ORALLY DISINTEGRATING / Bionpharma Inc.

Browse ingredients in United States →